What is the main purpose of this filing?

This is a Form 10-Q filing, which is a quarterly report required by the SEC. Its purpose is to provide investors with an update on Bristol-Myers Squibb Co.'s financial performance and significant business activities during the second quarter of 1998.

Where can I find the detailed financial results for Bristol-Myers Squibb in this report?

The provided text is a directory listing of the SEC filing. To access the detailed financial statements, management's discussion and analysis, and other crucial financial information, you would need to access the full 10-Q document itself, typically available through the SEC's EDGAR database or the company's investor relations website.

What key areas should an investor focus on in the full 10-Q filing?

Investors should focus on revenue trends for key products, profitability (net income and EPS), operating expenses, cash flow from operations, any significant acquisitions or divestitures, and updates on the product pipeline and regulatory approvals. These elements provide insight into the company's current health and future growth prospects.

BRISTOL MYERS SQUIBB CO 10-Q Quarterly Report Q2 FY1998

Summary

Bristol-Myers Squibb Co. (BMY) filed its quarterly report for the period ending June 29, 1998. This filing provides a snapshot of the company's financial performance and operational highlights during the second quarter of 1998. Investors can look to this report for insights into revenue generation, profitability, and any significant business developments that may impact shareholder value. The report is essential for understanding the company's trajectory and making informed investment decisions. While the provided text is a directory listing and not the full 10-Q financial statements, it indicates that the company has submitted its required quarterly disclosure. Investors would typically examine the full report for details on sales of key products, earnings per share, operating expenses, cash flow, and any new product pipeline updates or regulatory approvals. The absence of detailed financial figures in this excerpt means a deeper dive into the actual filing document is necessary for comprehensive analysis.

Key Highlights

1Quarterly Report filed for the period ending June 29, 1998.
2Company is Bristol-Myers Squibb Co. (BMY).
3Filing date was August 12, 1998.
4This report provides updates on the company's financial performance for the second quarter.
5Investors should review the full 10-Q for detailed financial statements and operational data.
6The provided text is a directory listing, not the detailed financial content of the 10-Q.

BRISTOL MYERS SQUIBB CO Quarterly Report for Q2 Ended Jun 30, 1998

Summary

Key Highlights

Frequently Asked Questions